The Paris court has awarded it to the drug maker Eli Lilly 2800 A provisional compensation of ten thousand euros, To compensate for patent infringement of its cancer drugs.
A Paris court ruled against generic drugmaker Fresenius.Kirby (Fresenius Kabi) The provisional award is believed to be the largest ever awarded by a European court for patent infringement. The ruling is the latest development in a long-running interjurisdictional battle between Eli Lilly and generic drugmakers over pemetrexed's patents. Parallel proceedings are already under way in other European jurisdictions, Including the UK, Germany, Italy, Belgium and the Netherlands.
The European patent covers pemetrexed disodium active ingredient and vitamin B12 Or a mixture of its drug derivatives, It is used to inhibit the growth of tumors. Such claims, known as so-called Swiss-style patent claims, involve new uses for previously known ingredients. The brand name of Lilly's patented product Alimta. Eli Lilly has sued Fresenius.Kirby is in France Pemetrexed Fersenius Kabi Generic drugs sold under the name.
Reprinted from China Intellectual Property Network
disclaimer: This website reprint articles are from the Internet, Does not represent the views of this website or confirm the authenticity of its content. If the source is mislabeled or the copyright of the article is involved, Please contact this website, This website will be corrected in due course, delete, thank you.

Safeguard the rights of economic and trade hotspots











